~800 Covid-19 Vaccine Studies (Web-Based Google Spreadsheet)

I. Sources

Item	Title	Author	Publication	Date Published	URL	Archive Link
Original Article Linking To Source	“1000 Peer Reviewed Studies Questioning Covid-19 Vaccine Safety”	None Listed	Informed Choice Australia	1/20/2022	https://www.informedchoiceaustralia.com/post/1000-peer-reviewed-studies-questioning-covid-19-vaccine-safety	https://archive.is/G7iq0
Source PDF With Full List Of Studies & Definitions Of Side Effects Listed		None Listed	N/A	1/20/2022	https://download-files.wixmp.com/ugd/b5e5d1_5941492af6e94bf0905dbabd83b91d5a.pdf?token=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJpc3MiOiJ1cm46YXBwOmU2NjYzMGU3MTRmMDQ5MGFhZWExZjE0OWIzYjY5ZTMyIiwic3ViIjoidXJuOmFwcDplNjY2MzBlNzE0ZjA0OTBhYWVhMWYxNDliM2I2OWUzMiIsImF1ZCI6WyJ1cm46c2VydmljZTpmaWxlLmRvd25sb2FkIl0sImlhdCI6MTY0NDY5Mjc4OCwiZXhwIjoxNjQ0NzI4Nzk4LCJqdGkiOiJkYmExODE0MzA4ZjgiLCJvYmoiOltbeyJwYXRoIjoiL3VnZC9iNWU1ZDFfNTk0MTQ5MmFmNmU5NGJmMDkwNWRiYWJkODNiOTFkNWEucGRmIn1dXSwiYXR0YWNobWVudCI6eyJmaWxlbmFtZSI6IlVwZGF0ZWRfUGVlcl9SZXZpZXdlZF9tZWRpY2FsX3BhcGVyc19zdWJtaXR0ZWRfdG9fdmFyaW91c19tZWRpY2FsLnBkZiJ9fQ.fNCjKPIsZMLV29kHuENp4_UtWD0afnq3UT_T-Kg_LxM
Cited By	“HERE’S THE LIST: 1,000 Different Studies Show Extensive Evidence of COVID-19 Vaccines Adverse Events”	Jim Hoft	Gateway Pundit	2/9/2022	https://www.thegatewaypundit.com/2022/02/list-1000-different-studies-show-extensive-evidence-covid-19-vaccines-adverse-events/	https://ar

II. Notes

Notes For The Reviewer

I. Quantity of Research Listed

1. The preponderance of studies does not in and of itself suggest an overwhelming amount of evidence concerning side effects. It is up to the reader to review each one individually and draw their own conclusions.

2. The same study may be published as two different articles, or a variation of a single study may be published twice. This was not assessed in compiling the list.

II. De-Duplication – Potential Errors

2. The entries have been de-duplicated in an automated fashion. Some non-duplicative links may have been removed in error.

3. In the de-duplication process, studies which crossed multiple categories will only be listed once. As a result, the significance of a side effect in a particular category may erroneously appear to be reduced.

III. Archive Link For This Spreadsheet

https://archive.is/3QsOR

III. Data

Access Online Spreadsheet: Click here.

View contents of spreadsheet: See below.

Category	Title	URL
Acute Coronary Syndrome	Mrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing	https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
Acute Eosinophilic Pneumonia	Acute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222	https://pubmed.ncbi.nlm.nih.gov/34812326/
Acute Hemichorea-Hemibalismus	Acute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccination	https://pubmed.ncbi.nlm.nih.gov/34581453/
Acute Hyperactive Encephalopathy	Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34325334/
Acute Hyperactive Encephalopathy	Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone	https://www.sciencedirect.com/science/article/pii/S2049080121007536
Acute Hyperactive Encephalopathy	Post-vaccinal encephalitis after ChAdOxnCov-19	https://pubmed.ncbi.nlm.nih.gov/34324214/
Acute Inflammatory Neuropathies	Reporting of acute inflammatory neuropathies with COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34579259/
Acute Kidney Injury	Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34352309/
Acute Kidney Injury	Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination	https://pubmed.ncbi.nlm.nih.gov/34362727/
Acute Kidney Injury	Minimal change disease and acute kidney injury after Pfizer-BioNTech COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34000278/
Acute Kidney Injury	Minimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34242687/
Acute lympholysis	Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34429981/
Acute Macular Neuroretinopathy	Bilateral acute macular neuroretinopathy after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34287612/
Acute Myelitis	A case of longitudinally extensive transverse myelitis following Covid-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34182207/
Acute Myelitis	Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34131771/
Acute Myelitis	Acute myelitis and ChAdOxnCoV-19 vaccine	https://www.sciencedirect.com/science/article/pii/S0165572821002137
Acute Myelitis	Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)	https://pubmed.ncbi.nlm.nih.gov/33981305/
Acute Myelitis	Acute transverse myelitis after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34482455/
Acute Myelitis	Acute transverse myelitis following inactivated COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34370410/
Acute Myelitis	Extensive longitudinal transverse myelitis after ChAdOxnCOV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34641797/
Acute Myelitis	Extensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34507942/
Acute Myelitis	Longitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34849183/
Acute Myelitis	Post COVID-19 transverse myelitis; a with review of the literature	https://pubmed.ncbi.nlm.nih.gov/34457267/
Allergic Reactions	Allergenic components of the mRNA-127vaccine for COVID-19	https://pubmed.ncbi.nlm.nih.gov/33657648/
Allergic Reactions	Allergic reactions after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34463751/
Allergic Reactions	Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience	https://pubmed.ncbi.nlm.nih.gov/34474708/
Allergic Reactions	Allergic reactions to COVID-19 vaccines	https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447
Allergic Reactions	Allergic reactions to the first COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33320974/
Allergic Reactions	An academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history	https://www.sciencedirect.com/science/article/pii/S2213219821007972
Allergic Reactions	Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open, 4(9), e21255doi	https://www.ncbi.nlm.nih.gov/pubmed/34533570
Allergic Reactions	Association of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34698847/
Allergic Reactions	Pfizer Vaccine Raises Allergy Concerns	https://pubmed.ncbi.nlm.nih.gov/33384356/
Allergic Reactions	Polyethylene glycole allergy of the SARS CoVvaccine recipient	https://pubmed.ncbi.nlm.nih.gov/33919151/
Allergic Reactions	Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease	https://pubmed.ncbi.nlm.nih.gov/33752263/
Allergic Reactions	Severe Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA	https://pubmed.ncbi.nlm.nih.gov/33643776/
Allergic Reactions	Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA	https://www.ncbi.nlm.nih.gov/pubmed/33643776
Allergic Reactions	Acute Allergic Reactions to mRNA COVID-19 Vaccines	https://pubmed.ncbi.nlm.nih.gov/33683290/
Alopecia Areata	Recurrence of alopecia areata after covid-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34741583/
Amyotrophic Neuralgia	Amyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19	https://pubmed.ncbi.nlm.nih.gov/34330677/
Anaphylaxis	.IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/34318537/
Anaphylaxis	Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/33571463/
Anaphylaxis	Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States, December 14-23, 20 MMWR Morb Mortal Wkly Rep, 70(2), 46-doi	https://www.ncbi.nlm.nih.gov/pubmed/33444297
Anaphylaxis	Allergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021	https://pubmed.ncbi.nlm.nih.gov/33507892/
Anaphylaxis	Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021	https://pubmed.ncbi.nlm.nih.gov/33641268/
Anaphylaxis	Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer BioNTech COVID-19 vaccine – United States, December 14-23, 2020	https://pubmed.ncbi.nlm.nih.gov/33444297/
Anaphylaxis	Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer BioNTech COVID-19 vaccine – United States, December 1to 23, 2020	https://pubmed.ncbi.nlm.nih.gov/33641264/
Anaphylaxis	Allergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer BioNTech COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33475702/
Anaphylaxis	Anaphylactic reactions to COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/33846043/188
Anaphylaxis	Anaphylaxis after Modern COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34734159/
Anaphylaxis	Anaphylaxis Associated with COVID-19 mRNA Vaccines	https://pubmed.ncbi.nlm.nih.gov/33932618/
Anaphylaxis	Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria	https://pubmed.ncbi.nlm.nih.gov/33851711/
Anaphylaxis	Anaphylaxis induced by CoronaVac COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34675550/
Anaphylaxis	Anaphylaxis reactions to Pfizer BNT162bvaccine	https://pubmed.ncbi.nlm.nih.gov/34579211/
Anaphylaxis	Biphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19	https://pubmed.ncbi.nlm.nih.gov/34050949/
Anaphylaxis	Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result	https://pubmed.ncbi.nlm.nih.gov/34343674/
Anaphylaxis	COVID-19 vaccine-associated anaphylaxis	https://www.sciencedirect.com/science/article/pii/S1939455121000119.
Anaphylaxis	Cumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan	https://pubmed.ncbi.nlm.nih.gov/34347278/
Anaphylaxis	Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan	https://www.ncbi.nlm.nih.gov/pubmed/34347278
Anaphylaxis	Elevated rates of anaphylaxis after vaccination with Pfizer BNT162bmRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data	https://pubmed.ncbi.nlm.nih.gov/34128049/
Anaphylaxis	Immunization practices and risk of anaphylaxis	https://pubmed.ncbi.nlm.nih.gov/34269740/
Anaphylaxis	Polyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33825239/
Anaphylaxis	Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine	https://pubmed.ncbi.nlm.nih.gov/33834172/
Anaphylaxis	Relationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34215453/
Anaphylaxis	Reports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021	https://pubmed.ncbi.nlm.nih.gov/34414880/
Anaphylaxis	Reports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021	https://pubmed.ncbi.nlm.nih.gov/33576785/
Anaphylaxis	Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19	https://pubmed.ncbi.nlm.nih.gov/34020815/
ANCA Glomerulonephritis	ANCA glomerulonephritis following Modern COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34081948/
Angioimmunoblastic T-cell Lymphoma	Rapid progression of angioimmunoblastic T-cell lymphoma after BNT162bmRNA booster vaccination	https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/
Arthritis	Reactive arthritis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34033732/
Asthma	COVID vaccination and asthma exacerbation	https://www.ncbi.nlm.nih.gov/pubmed/34547487
Axillary adenopathy	Adenopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33625299/
Axillary adenopathy	Axillary adenopathy associated with COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33624520/
Axillary adenopathy	Axillary lymphadenopathy in patients with recent Covid-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34825530/
Axillary adenopathy	COVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET	https://www.sciencedirect.com/science/article/pii/S1930043321002612
Axillary adenopathy	COVID-19 vaccine-induced unilateral axillary adenopathy	https://pubmed.ncbi.nlm.nih.gov/34655312/
Axillary adenopathy	COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients	https://pubmed.ncbi.nlm.nih.gov/34836672/
Axillary adenopathy	Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34735411/
Axillary adenopathy	Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34292295/
Axillary adenopathy	Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography	https://pubmed.ncbi.nlm.nih.gov/34906409/
Axillary adenopathy	Unilateral axillary adenopathy in the setting of COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34298342/
Axillary adenopathy	Unilateral axillary lymphadenopathy related to COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34325221/
Bell’s Palsy	A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34272622/
Bell’s Palsy	Acute facial paralysis as a possible complication of SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/33975372/
Bell’s Palsy	Adverse event reporting and risk of Bell’s palsy after COVID-19 vaccination	https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.
Bell’s Palsy	Bell’s palsy after 2hours of mRNA-127SARS-CoV-mRNA-127vaccine	https://pubmed.ncbi.nlm.nih.gov/34336436/
Bell’s Palsy	Bell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34032902/
Bell’s Palsy	Bell’s palsy after COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S217358082100122X.
Bell’s Palsy	Bell’s palsy after COVID-19 vaccination with high antibody response in CSF	https://pubmed.ncbi.nlm.nih.gov/34322761/
Bell’s Palsy	Bell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsy	https://pubmed.ncbi.nlm.nih.gov/34621891/
Bell’s Palsy	Bell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy	https://www.sciencedirect.com/science/article/pii/S266635462100020X
Bell’s Palsy	Bell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-vaccines	https://pubmed.ncbi.nlm.nih.gov/34411532/
Bell’s Palsy	Bilateral facial nerve palsy and COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34522557/
Bell’s Palsy	Left Bell’s palsy after the first dose of mRNA-127SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34763263/
Bell’s Palsy	The association between COVID-19 vaccination and Bell’s palsy	https://pubmed.ncbi.nlm.nih.gov/34411533/
Bell’s Palsy	Type I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsy	https://pubmed.ncbi.nlm.nih.gov/33858693/
Bleeding episodes	Association between ChAdOxnCoV-19 vaccination and bleeding episodes	https://pubmed.ncbi.nlm.nih.gov/34479760/
Bleeding episodes	Blood clots and bleeding episodes after BNT162band ChAdOxnCoV-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0896841121000937
Blood Clots	Blood clots and bleeding after BNT162band ChAdOxnCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34174723/
Brain Death	Brain death in a vaccinated patient with COVID-19 infection	https://pubmed.ncbi.nlm.nih.gov/34656887/
Brain Haemorrhage (Includes Term	Fatal brain haemorrhage after COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33928772/
Bullous Drug Eruption	Bullous drug eruption after the second dose of COVID-19 mRNA-127(Moderna) vaccine	https://www.sciencedirect.com/science/article/pii/S1876034121001878.
Bullous Drug Eruption	Widespread fixed bullous drug eruption after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34482558/
Capillary Leak Syndrome (Includes Term	Fatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma	https://pubmed.ncbi.nlm.nih.gov/34459725/
Cardiac	A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doi	https://www.ncbi.nlm.nih.gov/pubmed/34808708
Cardiac	Cardiac complications following mRNA COVID-19 vaccines	https://www.ncbi.nlm.nih.gov/pubmed/34921468
Cardiac	Temporal relationship between the second dose of BNT162bmRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-infection	https://www.sciencedirect.com/science/article/pii/S2352906721000622
Cardiac	Transient cardiac injury in adolescents receiving the BNT162bmRNA COVID-19 vaccine	https://journals.lww.com/pidj/Abstract/9000/
Cardiac	Transient Cardiac Injury in Adolescents Receiving the BNT162bmRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e3 doi	https://www.ncbi.nlm.nih.gov/pubmed/34077949
Cardiovascular events	Be alert to the risk of adverse cardiovascular events after COVID-19 vaccination	https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033
Cardiovascular Events	Cardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOxnCoV-19, and Ad2COVS vaccines	https://pubmed.ncbi.nlm.nih.gov/34710832/
Central Serous Retinopathy	Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine	https://www.sciencedirect.com/science/article/pii/S2451993621001456.
Central Vein Occlusion	Central retinal vein occlusion after vaccination with SARS-CoV-mRNA	https://pubmed.ncbi.nlm.nih.gov/34571653/
Cerebral Venous Thrombosis	A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination	https://pubmed.ncbi.nlm.nih.gov/34274191/
Cerebral Venous Thrombosis	A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0735675721005714
Cerebral Venous Thrombosis	A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33917902/
Cerebral Venous Thrombosis	Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34247246/
Cerebral Venous Thrombosis	Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)	https://pubmed.ncbi.nlm.nih.gov/34092166/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis after ChAdOxnCov-19 vaccination with a misleading first brain MRI	https://pubmed.ncbi.nlm.nih.gov/34244448/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis after vaccination	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33845870/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34333995/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34293217/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV- vaccination with adenovirus and after COVID-19	https://www.sciencedirect.com/science/article/pii/S0735109721051949
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV- vaccination with adenovirus and after COVID-19	https://pubmed.ncbi.nlm.nih.gov/34116145/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis negative for anti-PFantibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation	https://www.sciencedirect.com/science/article/pii/S1871402121002046
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis weeks after first dose of SARS-CoV-mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34101024/
Cerebral Venous Thrombosis	Cerebral venous sinus thrombosis weeks after the first dose of SARS-CoV- mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34101024/
Cerebral Venous Thrombosis	Cerebral venous thrombosis after BNT162bmRNA SARS-CoV-vaccine	https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098
Cerebral Venous Thrombosis	Cerebral venous thrombosis after the BNT162bmRNA SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34111775/
Cerebral Venous Thrombosis	Cerebral venous thrombosis and myeloproliferative neoplasms	https://pubmed.ncbi.nlm.nih.gov/34453762/
Cerebral Venous Thrombosis	Cerebral venous thrombosis and thrombocytopenia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33878469/
Cerebral Venous Thrombosis	Cerebral venous thrombosis associated with COVID-19 vaccine in Germany	https://pubmed.ncbi.nlm.nih.gov/34288044/
Cerebral Venous Thrombosis	Cerebral venous thrombosis associated with the covid-19 vaccine in Germany	https://onlinelibrary.wiley.com/doi/10.1002/ana.26172
Cerebral Venous Thrombosis	Cerebral venous thrombosis developing after vaccination. COVID-19	https://pubmed.ncbi.nlm.nih.gov/34695859/
Cerebral Venous Thrombosis	Cerebral venous thrombosis following BNT162bmRNA vaccination of BNT162b against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34133027/
Cerebral Venous Thrombosis	Cerebral venous thrombosis following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34045111/
Cerebral Venous Thrombosis	Cerebral venous thrombosis induced by SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34090750/
Cerebral Venous Thrombosis	COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33863748/
Cerebral Venous Thrombosis	Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV- mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/33687691/
Cerebral Venous Thrombosis	Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/33914590/
Cerebral Venous Thrombosis	Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0213485321000839
Cerebral Venous Thrombosis	Lethal cerebral venous sinus thrombosis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33983464/
Cerebral Venous Thrombosis	Massive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19	https://pubmed.ncbi.nlm.nih.gov/34373991/
Cerebral Venous Thrombosis	Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34261296/
Cerebral Venous Thrombosis	The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34001390/
Cerebral Venous Thrombosis	Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford AstraZeneca COVID-19	https://www.sciencedirect.com/science/article/pii/S235255682100093X
Cerebral Venous Thrombosis	Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate	https://pubmed.ncbi.nlm.nih.gov/34393988/
Cerebral Venous Thrombosis	Venous sinus thrombosis after vaccination with ChAdOxnCov-19	https://pubmed.ncbi.nlm.nih.gov/34420802/
Chest Pain	Chest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna	https://pubmed.ncbi.nlm.nih.gov/34866106/
CNS Demyelination	A systematic review of cases of CNS demyelination following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34839149/
CNS Inflammation	COVID-19 mRNA vaccine causing CNS inflammation	https://link.springer.com/article/10.1007/s00415-021-10780-7
Coagulopathies	Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways	https://pubmed.ncbi.nlm.nih.gov/34639132/
Cutaneous Adverse Effects	Cutaneous adverse effects of available COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34518015/
Cutaneous Adverse Effects	Cutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19	https://pubmed.ncbi.nlm.nih.gov/34661934/
Cutaneous Adverse Effects	Rare cutaneous adverse effects of COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34363637/
Cutaneous Reactions	Late cutaneous reactions after administration of COVID-19 mRNA vaccines	https://www.sciencedirect.com/science/article/pii/S2213219821007996
Depression	Depression after ChAdOx1-S / nCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34608345/
Eosinophilic Dermatosis	Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34753210/
Facial Nerve Palsy	COVID-19 vaccination association and facial nerve palsy	https://pubmed.ncbi.nlm.nih.gov/34165512/
Facial Nerve Palsy	Facial nerve palsy after administration of COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/34492394/
Facial Nerve Palsy	Facial nerve palsy following administration of COVID-19 mRNA vaccines	https://www.sciencedirect.com/science/article/pii/S1201971221007049
Facial Nerve Palsy	Peripheral facial nerve palsy after vaccination with BNT162b(COVID-19)	https://pubmed.ncbi.nlm.nih.gov/33734623/
Facial Nerve Palsy	Sequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34281950/
Gastroparesis	Gastroparesis after Pfizer-BioNTech COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34187985/
Graves’ Disease	Two cases of Graves’ disease after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/33858208/
Gross Hematuria	Gross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropaty	https://pubmed.ncbi.nlm.nih.gov/33771584/
Guillain-Barré syndrome	A case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34567447/
Guillain-Barré syndrome	A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM antibodies after first dose of COVID-19 BNT162bmRNA vaccine (Pfizer)	https://pubmed.ncbi.nlm.nih.gov/34871447/
Guillain-Barré syndrome	A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19	https://pubmed.ncbi.nlm.nih.gov/34449715/
Guillain-Barré syndrome	A rare case of Guillain-Barré syndrome after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34671572/
Guillain-Barré syndrome	A rare variant of Guillain-Barré syndrome after vaccination with Ad2COVS	https://pubmed.ncbi.nlm.nih.gov/34703690/
Guillain-Barré syndrome	A variant of Guillain-Barré syndrome after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34370408/
Guillain-Barré syndrome	Association of receipt association of Ad2COVS COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021	https://jamanetwork.com/journals/jama/fullarticle/2785009
Guillain-Barré syndrome	AstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania	https://pubmed.ncbi.nlm.nih.gov/34560365/
Guillain-Barré syndrome	Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34261746/
Guillain-Barré syndrome	Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine	https://pubmed.ncbi.nlm.nih.gov/34808658/
Guillain-Barré syndrome	COVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy	https://onlinelibrary.wiley.com/doi/10.1002/ana.26258.
Guillain-Barré syndrome	COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect	https://pubmed.ncbi.nlm.nih.gov/34484780/
Guillain-Barré syndrome	COVID-19, Guillain-Barré and vaccineA dangerous mix	https://pubmed.ncbi.nlm.nih.gov/34108736/
Guillain-Barré syndrome	Facial diplegia	https://pubmed.ncbi.nlm.nih.gov/34447646/
Guillain-Barré syndrome	GMganglioside antibody and COVID-19-related Guillain Barre syndrome	https://www.sciencedirect.com/science/article/pii/S2666354621000065
Guillain-Barré syndrome	Guillain-Barré syndrome after AstraZeneca COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0303846721004169
Guillain-Barré syndrome	Guillain-Barre syndrome after BNT162bCOVID-19 vaccine	https://link.springer.com/article/10.1007%2Fs10072-021-05523-5.
Guillain-Barré syndrome	Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34114256/
Guillain-Barré syndrome	Guillain-Barré syndrome after ChAdOxnCoV-19 COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34548920/
Guillain-Barré syndrome	Guillain-Barre syndrome after COVID-19 mRNA-127vaccine	https://pubmed.ncbi.nlm.nih.gov/34767184/
Guillain-Barré syndrome	Guillain-Barre syndrome after COVID-19 vaccination in an adolescent	https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.
Guillain-Barré syndrome	Guillain-Barré syndrome after SARS-CoV-vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome	https://pubmed.ncbi.nlm.nih.gov/34810163/
Guillain-Barré syndrome	Guillain-Barre syndrome after the first dose of COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34779385/
Guillain-Barré syndrome	Guillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34796417/
Guillain-Barré syndrome	Guillain-Barre syndrome after the first dose of SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/33968610/
Guillain-Barré syndrome	Guillain-Barré syndrome after the first dose of SARS-CoV-vaccine	https://www.sciencedirect.com/science/article/pii/S2214250921000998.
Guillain-Barré syndrome	Guillain-Barre syndrome after the first injection of ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34217513/
Guillain-Barré syndrome	Guillain-Barré syndrome after the first injection of ChAdOxnCoV-19 vaccine	https://www.sciencedirect.com/science/article/pii/S0035378721005853.
Guillain-Barré syndrome	Guillain-Barré syndrome associated with COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34648420/
Guillain-Barré syndrome	Guillain-Barre syndrome following SARS-CoV-vaccination in 19 patients	https://pubmed.ncbi.nlm.nih.gov/34644738/
Guillain-Barré syndrome	Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-vaccines	https://onlinelibrary.wiley.com/doi/10.1002/ana.26218
Guillain-Barré syndrome	Guillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19	https://www.sciencedirect.com/science/article/pii/S0736467921006442
Guillain-Barré syndrome	Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients	https://pubmed.ncbi.nlm.nih.gov/34649856/
Guillain-Barré syndrome	Guillian Barré syndrome after vaccination with mRNA-127against COVID-19	https://pubmed.ncbi.nlm.nih.gov/34477091/
Guillain-Barré syndrome	Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-mRNA-based vaccine	https://pubmed.ncbi.nlm.nih.gov/34722067/
Guillain-Barré syndrome	Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34848426/
Guillain-Barré syndrome	Neurological complications of COVID-19	https://pubmed.ncbi.nlm.nih.gov/33758714/
Guillain-Barré syndrome	Rate of recurrent Guillain-Barré syndrome after COVID-19 BNT162bmRNA vaccine	https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
Guillain-Barré syndrome	SARS-CoV-vaccines are not safe for those with Guillain-Barre syndrome following vaccination	https://www.sciencedirect.com/science/article/pii/S2049080121005343
Guillain-Barré syndrome	SARS-CoV-vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy	https://pubmed.ncbi.nlm.nih.gov/34525410/
Guillain-Barré syndrome	Sensory Guillain-Barré syndrome after ChAdOxnCov-19 vaccine	https://www.sciencedirect.com/science/article/pii/S0165572821002186
Guillain-Barré syndrome	Sensory Guillain-Barré syndrome following ChAdOxnCov-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34416410/
Guillain-Barré syndrome	Variant Guillain-Barré syndrome occurring after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34114269/
Haemorrhage	Acral hemorrhage after administration of the second dose of SARS-CoV-vaccine. A post-vaccination reaction	https://pubmed.ncbi.nlm.nih.gov/34092400/742
Haemorrhage	Lobar hemorrhage with ventricular rupture shortly after the first dose of a SARS CoV-mRNA-based SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34729467/
Haemorrhage	Lobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA based SARS-CoV-vaccine	https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/
Haemorrhage	Retinal hemorrhage after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34884407/
Hailey-Hailey disease	Hailey-Hailey disease exacerbation after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34436620/
Headache	Headache attributed to COVID-19 (SARS-CoV-coronavirus) vaccination with the ChAdOxnCoV-19 (AZD1222) vaccine	https://pubmed.ncbi.nlm.nih.gov/34313952/
Hematologic conditions	Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-vaccination	https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic
Hemolysis	COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria	https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in
Hemophagocytic lymphohistiocytosis	Hemophagocytic lymphohistiocytosis after vaccination with ChAdOxnCov-19	https://pubmed.ncbi.nlm.nih.gov/34406660/
Hemophagocytic lymphohistiocytosis	Hemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx nCoV-19)	https://pubmed.ncbi.nlm.nih.gov/34862234/
Henoch-Schonlein Purpura	A rare case of Henoch-Schönlein purpura after a of COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34518812/
Henoch-Schonlein Purpura	Henoch-Schönlein purpura following the first dose of COVID-19 viral vector vaccine	https://pubmed.ncbi.nlm.nih.gov/34696186/
Henoch-Schonlein Purpura	Henoch-Schönlein purpura occurring after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34247902/
Herpes Simplex Virus	Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34487581/
Hypercoagulability	COVID-19 vaccine in patients with hypercoagulability disorders	https://pubmed.ncbi.nlm.nih.gov/34786893/
Immune-Mediated Disease Outbreaks	Autoimmune encephalitis after ChAdOx1-S SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34846583/
Immune-Mediated Disease Outbreaks	Immune-mediated disease outbreaks or recent-onset disease in 2subjects after mRNA/DNA vaccination against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/33946748/
Immune-Mediated Disease Outbreaks	Severe autoimmune hemolytic anemia after receipt of SARS-CoV-mRNA vaccine	https://onlinelibrary.wiley.com/doi/10.1111/trf.16672
Immune-Mediated Disease Outbreaks	Severe autoimmune hemolytic autoimmune anemia after receiving SARS-CoV- mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34549821/
Immune-Mediated Disease Outbreaks	Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study	https://www.ncbi.nlm.nih.gov/pubmed/34127481
Immune-Mediated Hepatitis	Autoimmune hepatitis after COVID vaccine	https://pubmed.ncbi.nlm.nih.gov/34225251/
Immune-Mediated Hepatitis	Autoimmune hepatitis developing after ChAdOxnCoV-19 vaccine (Oxford AstraZeneca)	https://pubmed.ncbi.nlm.nih.gov/34171435/
Immune-Mediated Hepatitis	Autoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19)	https://pubmed.ncbi.nlm.nih.gov/33862041/
Immune-Mediated Hepatitis	Autoimmune hepatitis triggered by SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34332438/
Immune-Mediated Hepatitis	Autoimmune hepatitis triggered by vaccination against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34332438/
Immune-Mediated Hepatitis	Hepatitis C virus reactivation after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34512037/
Immune-Mediated Hepatitis	Immune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed	https://www.sciencedirect.com/science/article/pii/S0168827821020936
Inflammatory Myositis	Inflammatory myositis after vaccination with ChAdOx1	https://pubmed.ncbi.nlm.nih.gov/34585145/
Interstitial lung disease	Vaccine-induced interstitial lung disease	https://pubmed.ncbi.nlm.nih.gov/34510014/
Intracerebral Haemorrhage	Aphasia seven days after the second dose of an mRNA-based SARS-CoV-vaccine. Brain MRI revealed an intracerebral haemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. https	https://www.sciencedirect.com/science/article/pii/
Intracerebral Haemorrhage	Incidence of acute ischemic stroke after coronavirus vaccination in Indonesia	https://pubmed.ncbi.nlm.nih.gov/34579636/
Intracerebral Haemorrhage	Intracerebral haemorrhage twelve days after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34477089/
Intracerebral Haemorrhage	Major hemorrhagic stroke after ChAdOxnCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34273119/
iTTP episode	First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34105244/
Keratolysis (also termed	Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine	https://pubmed.ncbi.nlm.nih.gov/34483273/
Kounis Syndrome	Kounis syndrome type induced by inactivated SARS-COV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34148772/
Lipschütz ulcers (Vaginal ulcers)	Lipschütz ulcers after AstraZeneca COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34366434/
Lymphadenopathy	A case of cervical lymphadenopathy following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34141500/
Lymphadenopathy	Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021	https://pubmed.ncbi.nlm.nih.gov/33706861/
Lymphadenopathy	Adverse events of COVID injection that may occur in children.Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021	https://pubmed.ncbi.nlm.nih.gov/33706861/
Lymphadenopathy	Cervical lymphadenopathy after coronavirus disease vaccination 2019	https://pubmed.ncbi.nlm.nih.gov/34526175/
Lymphadenopathy	COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET / CT	https://pubmed.ncbi.nlm.nih.gov/33591026/
Lymphadenopathy	COVID-19 post-vaccination lymphadenopathy	https://pubmed.ncbi.nlm.nih.gov/34432391/
Lymphadenopathy	COVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinic	https://pubmed.ncbi.nlm.nih.gov/33947605/
Lymphadenopathy	COVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israel	https://pubmed.ncbi.nlm.nih.gov/34257025/
Lymphadenopathy	COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies	https://pubmed.ncbi.nlm.nih.gov/34719892/
Lymphadenopathy	Evolution of Lymphadenopathy at Pet/MRI after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33625301/
Lymphadenopathy	Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33625301/
Lymphadenopathy	Hypermetabolic lymphadenopathy after administration of BNT162bmRNA vaccine Covid-19	https://pubmed.ncbi.nlm.nih.gov/33774684/
Lymphadenopathy	Lymphadenopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33985872/
Lymphadenopathy	Lymphadenopathy associated with COVID-19 vaccination on FDG PET/CT
Lymphadenopathy	Lymphadenopathy associated with the COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33786231/
Lymphadenopathy	Lymphadenopathy in COVID-19 vaccine recipients	https://pubmed.ncbi.nlm.nih.gov/33625300/
Lymphadenopathy	Massive cervical lymphadenopathy following vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34601889/
Lymphadenopathy	Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding	https://pubmed.ncbi.nlm.nih.gov/33661328/
Lymphadenopathy	Regional lymphadenopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34731748/
Lymphadenopathy	Supraclavicular lymphadenopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33685772/
Lymphadenopathy	Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea	https://pubmed.ncbi.nlm.nih.gov/34116295/
Lymphadenopathy	Unilateral lymphadenopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33713605/
Macroscopic Hematuria	A case of outbreak of macroscopic hematuria and IgA nephropathy after SARS CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/33932458/
Macroscopic Hematuria	Hematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOxnCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34620638/
Metabolic Syndrome	Change in blood viscosity after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34868465/
Miller Fisher Syndrome	Miller Fisher syndrome after 2019 BNT162bmRNA coronavirus vaccination	https://pubmed.ncbi.nlm.nih.gov/34789193/
Miller Fisher Syndrome	Miller Fisher syndrome after Pfizer COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34817727/
Multiple sclerosis	Acute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab	https://pubmed.ncbi.nlm.nih.gov/34015240
Multiple sclerosis	Humoral response induced by Prime-Boost vaccination with ChAdOxnCoV-19 and BNT162bmRNA vaccines in a patient with multiple sclerosis treated with teriflunomide	https://pubmed.ncbi.nlm.nih.gov/34696248/
Multiple sclerosis	Severe relapse of multiple sclerosis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34447349/
Multisystem Inflammatory Syndrome (includes term	Post-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection	https://pubmed.ncbi.nlm.nih.gov/34852213/
Myocardial Injury	Acute myocardial injury after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34219532/
Myocardial Injury	Acute Myocardial Injury Following COVID-19 Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34219532
Myocarditis	Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?	https://pubmed.ncbi.nlm.nih.gov/34702550/
Myocarditis	A case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273	https://pubmed.ncbi.nlm.nih.gov/34703815/
Myocarditis	A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13(9), e17890. doi	https://www.ncbi.nlm.nih.gov/pubmed/34660088
Myocarditis	A report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics	https://pubmed.ncbi.nlm.nih.gov/34601006/
Myocarditis	A series of patients with myocarditis after vaccination against SARS-CoV-with mRNA-1279 and BNT162b2	https://www.sciencedirect.com/science/article/pii/S1936878X21004861
Myocarditis	A series of patients with myocarditis after vaccination against SARS-CoV-with mRNA-79 and BNT162b2	https://pubmed.ncbi.nlm.nih.gov/34246585/
Myocarditis	A Series of Patients With Myocarditis Following SARS CoV-Vaccination With mRNA-1279 and BNT162b JACC Cardiovasc Imaging, 14(9), 1862-18doi	https://www.ncbi.nlm.nih.gov/pubmed/34246585
Myocarditis	Acute myocardial infarction and myocarditis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34586408/
Myocarditis	Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doi	https://www.ncbi.nlm.nih.gov/pubmed/34586408
Myocarditis	Acute myocardial infarction within 2hours after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34292611/
Myocarditis	Acute myocarditis after 2019 coronavirus disease vaccination	https://pubmed.ncbi.nlm.nih.gov/34734821/
Myocarditis	Acute myocarditis after a second dose of COVID-19 mRNA vaccine	https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext
Myocarditis	Acute myocarditis after administration of BNT162bvaccine	https://www.sciencedirect.com/science/article/pii/S2214250921001530
Myocarditis	Acute myocarditis after administration of the second dose of BNT162bCOVID-19 vaccine	https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/
Myocarditis	Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-infection	https://www.sciencedirect.com/science/article/pii/S1930043321005549
Myocarditis	Acute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-infection	https://pubmed.ncbi.nlm.nih.gov/34367386/
Myocarditis	Acute myocarditis after COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0248866321007098
Myocarditis	Acute myocarditis after SARS-CoV-mRNA-7mRNA vaccination	https://pubmed.ncbi.nlm.nih.gov/34308326/
Myocarditis	Acute myocarditis after SARS-CoV-vaccination in a 24-year-old male	https://pubmed.ncbi.nlm.nih.gov/34334935/
Myocarditis	Acute myocarditis after SARS-CoV-vaccination in a 24-year-old man	https://www.sciencedirect.com/science/article/pii/S0870255121003243
Myocarditis	Acute myocarditis after vaccination with COVID-19 mRNA in adults aged 1years or older	https://pubmed.ncbi.nlm.nih.gov/34605853/
Myocarditis	Acute myocarditis after vaccination with SARS-CoV-mRNA-127mRNA	https://www.sciencedirect.com/science/article/pii/S2589790X21001931
Myocarditis	Acute myocarditis associated with anti-COVID-19 vaccination	https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.
Myocarditis	Acute myocarditis associated with COVID-19 vaccination	https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/
Myocarditis	Acute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease	https://pubmed.ncbi.nlm.nih.gov/34866122/
Myocarditis	Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-infection. Radiol Case Rep, 16(11), 3321-33doi	https://www.ncbi.nlm.nih.gov/pubmed/34367386
Myocarditis	Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 1 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doi	https://www.ncbi.nlm.nih.gov/pubmed/34605853
Myocarditis	Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome), 22(11), 891-89 doi	https://www.ncbi.nlm.nih.gov/pubmed/34709227
Myocarditis	Acute myocarditis in a young adult two days after vaccination with Pfizer	https://pubmed.ncbi.nlm.nih.gov/34709227/
Myocarditis	Acute myopericarditis after COVID-19 vaccination in adolescents	https://pubmed.ncbi.nlm.nih.gov/34589238/
Myocarditis	Acute symptomatic myocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34088762/
Myocarditis	Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination	https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478
Myocarditis	Association of myocarditis with COVID-19 messenger RNA BNT162bvaccine COVID-19 in a case series of children	https://pubmed.ncbi.nlm.nih.gov/34374740/
Myocarditis	Association of myocarditis with COVID-19 messenger RNA vaccine BNT162bin a case series of children	https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
Myocarditis	Association of myocarditis with COVID-19 mRNA vaccine in children	https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-covid-19-vaccine-in-children/
Myocarditis	Biopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man	https://pubmed.ncbi.nlm.nih.gov/34487236/
Myocarditis	Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male	https://www.ncbi.nlm.nih.gov/pubmed/34487236
Myocarditis	Biventricular systolic dysfunction in acute myocarditis after SARS-CoV- mRNA-7vaccination	https://pubmed.ncbi.nlm.nih.gov/34601566/
Myocarditis	Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA	https://pubmed.ncbi.nlm.nih.gov/34402228/
Myocarditis	Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), e2doi	https://www.ncbi.nlm.nih.gov/pubmed/34402228
Myocarditis	Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doi	https://www.ncbi.nlm.nih.gov/pubmed/34704459
Myocarditis	Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34496880
Myocarditis	Cardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination	https://jcmronline.biomedcentral.com/articles/10.1186/s12968-021-00795-4
Myocarditis	Occurrence of acute infarct-like myocarditis following COVID-19 vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34333695
Myocarditis	Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34849657
Myocarditis	Clinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA	https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis
Myocarditis	Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults	https://pubmed.ncbi.nlm.nih.gov/34865500/
Myocarditis	Clinically Suspected Myocarditis Temporally Related to COVID- Vaccination in Adolescents and Young Adults. Circulation. doi	https://www.ncbi.nlm.nih.gov/pubmed/34865500
Myocarditis	COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-5doi	https://www.ncbi.nlm.nih.gov/pubmed/34564344
Myocarditis	COVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis	https://www.mdpi.com/2036-7503/13/3/61.
Myocarditis	COVID-19 mRNA vaccination and myocarditis	https://pubmed.ncbi.nlm.nih.gov/34268277/
Myocarditis	COVID-19 Vaccination Associated with Myocarditis in Adolescents	https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf
Myocarditis	COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, 148(5). doi	https://www.ncbi.nlm.nih.gov/pubmed/34389692
Myocarditis	COVID-19 vaccine and myocarditis	https://pubmed.ncbi.nlm.nih.gov/34399967/
Myocarditis	COVID-19 vaccine-induced myocarditis	https://www.sciencedirect.com/science/article/pii/S1871402121002253
Myocarditis	COVID-19 vaccines and myocarditis	https://pubmed.ncbi.nlm.nih.gov/34246566/
Myocarditis	Eosinophilic Myocarditis Following Coronavirus Disease 20 (COVID-) Vaccination. Circ J. doi	https://www.ncbi.nlm.nih.gov/pubmed/34955479
Myocarditis	Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children	https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-1360706.
Myocarditis	Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children	https://www.ncbi.nlm.nih.gov/pubmed/34402230
Myocarditis	Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co vaccination	https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179
Myocarditis	Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada	https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1
Myocarditis	Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doi	https://www.ncbi.nlm.nih.gov/pubmed/34860360
Myocarditis	Ga-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34746968/
Myocarditis	In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine	https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038
Myocarditis	Lymphohistocytic myocarditis after vaccination with COVID-19 Ad2COVS viral vector	https://www.sciencedirect.com/science/article/pii/S2352906721001573
Myocarditis	Lymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad2COVS	https://pubmed.ncbi.nlm.nih.gov/34514078/
Myocarditis	mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-3doi	https://www.ncbi.nlm.nih.gov/pubmed/34393110
Myocarditis	Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-73	https://pubmed.ncbi.nlm.nih.gov/34848416/
Myocarditis	Myocarditis / pericarditis associated with COVID-19 vaccine	https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html
Myocarditis	Myocarditis after 2019 coronavirus disease mRNA vaccine	https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408
Myocarditis	Myocarditis after BNT162bmRNA Vaccine against Covid-19 in Israel. N Engl J Med, 385(23), 2140-21doi	https://www.ncbi.nlm.nih.gov/pubmed/34614328
Myocarditis	Myocarditis after BNT162bvaccination in a healthy male	https://pubmed.ncbi.nlm.nih.gov/34229940/
Myocarditis	Myocarditis after BNT162bvaccination in a healthy male. Am J Emerg Med, 50, 81e811-81edoi	https://www.ncbi.nlm.nih.gov/pubmed/34229940
Myocarditis	Myocarditis after COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/34546329/
Myocarditis	Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med, 385(23), 2132-21doi	https://www.ncbi.nlm.nih.gov/pubmed/34614329
Myocarditis	Myocarditis after Covid-19 vaccination in a large healthcare organization	https://www.nejm.org/doi/10.1056/NEJMoa2110737
Myocarditis	Myocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military	https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C
Myocarditis	Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “2male patients, including 2previously healthy military members, myocarditis was identified within days after receipt of the vaccine”	https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
Myocarditis	Myocarditis after mRNA vaccination against SARS-CoV-2, a case series	https://www.sciencedirect.com/science/article/pii/S2666602221000409
Myocarditis	Myocarditis after SARS-CoV-mRNA vaccination, a case series	https://pubmed.ncbi.nlm.nih.gov/34396358/
Myocarditis	Myocarditis after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34118375/
Myocarditis	Myocarditis after vaccination against covid-BMJ, 375, n3090. doi	https://www.ncbi.nlm.nih.gov/pubmed/34916217
Myocarditis	Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines https	https://www.cureus.com/articles/61030-myocarditis-and-othercardiovascular-complications-of-the-mrna-based-covid-19-vaccines
Myocarditis	Myocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34277198/
Myocarditis	Myocarditis and Other Cardiovascular Complications of the mRNA Based COVID- Vaccines. Cureus, 13(6), e155doi	https://www.ncbi.nlm.nih.gov/pubmed/34277198
Myocarditis	Myocarditis and Pericarditis After COVID-19 mRNA Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34375696
Myocarditis	Myocarditis and pericarditis after COVID-19 vaccination	https://jamanetwork.com/journals/jama/fullarticle/2782900
Myocarditis	Myocarditis and pericarditis after vaccination with COVID-19 mRNA	https://www.sciencedirect.com/science/article/pii/S0828282X21006243
Myocarditis	Myocarditis and Pericarditis following COVID-19 Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34834458
Myocarditis	Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34356586
Myocarditis	Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines	https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104
Myocarditis	Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi	https://www.ncbi.nlm.nih.gov/pubmed/34849667
Myocarditis	Myocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/34849667/
Myocarditis	Myocarditis and pericarditis in association with COVID-19 mRNA vaccination	https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/
Myocarditis	Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34805376
Myocarditis	Myocarditis associated with COVID-19 mRNA vaccination	https://pubs.rsna.org/doi/10.1148/radiol.2021211430
Myocarditis	Myocarditis associated with COVID-19 vaccination	https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236
Myocarditis	Myocarditis associated with COVID-19 vaccination in adolescents	https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357
Myocarditis	Myocarditis Associated with mRNA COVID- Vaccination. Radiology, 301(2), E409-E4doi	https://www.ncbi.nlm.nih.gov/pubmed/34282971
Myocarditis	Myocarditis associated with SARS-CoV-mRNA vaccination in children aged 1to 1years	https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
Myocarditis	Myocarditis associated with vaccination with COVID-19 mRNA	https://pubs.rsna.org/doi/10.1148/radiol.2021211430
Myocarditis	Myocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents	https://pubmed.ncbi.nlm.nih.gov/34704459/
Myocarditis	Myocarditis Following a COVID-19 Messenger RNA Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34840235
Myocarditis	Myocarditis following BNT162bmRNA Covid-19 mRNA vaccine in Israel	https://pubmed.ncbi.nlm.nih.gov/34614328/
Myocarditis	Myocarditis Following COVID-19 mRNA Vaccine	https://www.ncbi.nlm.nih.gov/pubmed/34734240
Myocarditis	Myocarditis following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34739045/
Myocarditis	Myocarditis following COVID-19 vaccination – A case series. Vaccine, 39(42), 6195-6200. doi	https://www.ncbi.nlm.nih.gov/pubmed/34535317
Myocarditis	Myocarditis following COVID-19 vaccination. Int J Cardiol Heart Vasc, 36, 1008doi	https://www.ncbi.nlm.nih.gov/pubmed/34568540
Myocarditis	Myocarditis following COVID-19 vaccination. Radiol Case Rep, 16(8), 22-21doi	https://www.ncbi.nlm.nih.gov/pubmed/34025885
Myocarditis	Myocarditis following immunization with Covid-19 mRNA	https://www.nejm.org/doi/full/10.1056/NEJMc2109975
Myocarditis	Myocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military	https://pubmed.ncbi.nlm.nih.gov/34185045/
Myocarditis	Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-120 doi	https://www.ncbi.nlm.nih.gov/pubmed/34185045
Myocarditis	Myocarditis Following mRNA COVID- Vaccine. Pediatr Emerg Care, 37(11), 583-5doi	https://www.ncbi.nlm.nih.gov/pubmed/34731877
Myocarditis	Myocarditis Following mRNA COVID-19 Vaccine	https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx
Myocarditis	Myocarditis following mRNA vaccination against SARS CoV-2, a case series. Am Heart J Plus, 8, 1000doi	https://www.ncbi.nlm.nih.gov/pubmed/34396358
Myocarditis	Myocarditis following vaccination with BNT162bin a healthy male	https://www.sciencedirect.com/science/article/pii/S0735675721005362
Myocarditis	Myocarditis following vaccination with Covid-19 in a large healthcare organization	https://pubmed.ncbi.nlm.nih.gov/34614329/
Myocarditis	Myocarditis following vaccination with COVID-19 messenger RNA	https://pubmed.ncbi.nlm.nih.gov/34840235/
Myocarditis	Myocarditis in the setting of a recent COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34712497/
Myocarditis	Myocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccines	https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600
Myocarditis	Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM. doi	https://www.ncbi.nlm.nih.gov/pubmed/34463755
Myocarditis	Myocarditis temporally associated with COVID-19 vaccination	https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.
Myocarditis	Myocarditis with COVID-19 mRNA vaccines	https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135
Myocarditis	Myocarditis With COVID-19 mRNA Vaccines. Circulation, 4(6), 471-4doi	https://www.ncbi.nlm.nih.gov/pubmed/34281357
Myocarditis	Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S1443950621011562
Myocarditis	Myocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34340927/
Myocarditis	Myocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination	https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext
Myocarditis	Occurrence of acute infarct-like myocarditis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34333695/
Myocarditis	Occurrence of acute infarct-like myocarditis after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34333695/
Myocarditis	Patients with acute myocarditis after COVID-19 mRNA vaccination	https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
Myocarditis	Patients with acute myocarditis after vaccination withCOVID-19 mRNA	https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
Myocarditis	Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1 doi	https://www.ncbi.nlm.nih.gov/pubmed/34185046
Myocarditis	Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination	https://academic.oup.com/jpids/article/10/10/962/6329543.
Myocarditis	Possible Association Between COVID-19 Vaccine and Myocarditis	https://pubmed.ncbi.nlm.nih.gov/34246586/
Myocarditis	Potential association between COVID-19 vaccine and myocarditis	https://www.sciencedirect.com/science/article/pii/S1936878X2100485X
Myocarditis	Premature myocardial infarction or side effect of COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33824804/
Myocarditis	Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/
Myocarditis	Recurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male	https://pubmed.ncbi.nlm.nih.gov/34166671/
Myocarditis	Reply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination”	https://www.ncbi.nlm.nih.gov/pubmed/34463770
Myocarditis	Risk of Myocarditis from COVID- Infection in People Under Age 20	https://www.ncbi.nlm.nih.gov/pubmed/34341797
Myocarditis	Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-infection. Nat Med. doi	https://www.ncbi.nlm.nih.gov/pubmed/34907393
Myocarditis	Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162bmRNA vaccine. Cardiol Young, 1- doi	https://www.ncbi.nlm.nih.gov/pubmed/34180390
Myocarditis	Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162bmRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34180390/
Myocarditis	Severe myocarditis associated with COVID-19 vaccine	https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext
Myocarditis	Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients	https://pubmed.ncbi.nlm.nih.gov/34696294/
Myocarditis	Should Tmapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doi	https://www.ncbi.nlm.nih.gov/pubmed/34933012
Myocarditis	STEMI mimicry	https://pubmed.ncbi.nlm.nih.gov/34756746/
Myocarditis	Symptomatic Acute Myocarditis in Adolescents after Pfizer-BioNTech COVID-19 Vaccination	https://pediatrics.aappublications.org/content/148/3/e2021052478
Myocarditis	Temporal association between COVID-19 vaccine Ad2COVS and acute myocarditis	https://www.sciencedirect.com/science/article/pii/S1553838921005789
Myocarditis	Temporal association between the COVID- Ad2COVS vaccine and acute myocarditis	https://www.ncbi.nlm.nih.gov/pubmed/34420869
Myocarditis	The new COVID-19 mRNA vaccine platform and myocarditis	https://pubmed.ncbi.nlm.nih.gov/34312010/
Myocarditis	Tmapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process. QJM. doi	https://www.ncbi.nlm.nih.gov/pubmed/34931681
Myocarditis	Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients	https://www.ncbi.nlm.nih.gov/pubmed/34237049
Myocarditis	Young male with myocarditis after mRNA-7coronavirus disease-2019 (COVID-19) mRNA vaccination	https://pubmed.ncbi.nlm.nih.gov/34744118/
Myocarditis	Young Male With Myocarditis Following mRNA-127Vaccination Against Coronavirus Disease-19 (COVID-19). Circ J. doi	https://www.ncbi.nlm.nih.gov/pubmed/34744118
Myocarditis	Myocarditis following COVID-19 mRNA vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34092429
Myocarditis	Myocarditis following COVID-19 mRNA vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34342500
Myopericarditis	Acute myocarditis after administration of BNT162bvaccine against COVID-19	https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X
Myopericarditis	Acute myopericarditis after COVID-19 vaccine in adolescents	https://pubmed.ncbi.nlm.nih.gov/34589238/
Myopericarditis	COVID-19 mRNA vaccination and development of CMR-confirmed myopericarditis	https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09
Myopericarditis	Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents	https://www.sciencedirect.com/science/article/pii/S0022347621007496
Myopericarditis	Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, doi	https://www.ncbi.nlm.nih.gov/pubmed/34332972
Myopericarditis	Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase	https://www.ncbi.nlm.nih.gov/pubmed/33406694
Myopericarditis	Insights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis	https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059
Myopericarditis	Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34453510/
Myopericarditis	Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model	https://t.co/j0IEM8cMXI
Myopericarditis	mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents	https://www.ncbi.nlm.nih.gov/pubmed/34952008
Myopericarditis	Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 1to 1Years of Age. J Pediatr, 238, 26-3edoi	https://www.ncbi.nlm.nih.gov/pubmed/34339728
Myopericarditis	Myopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescents	https://pubmed.ncbi.nlm.nih.gov/34228985/
Myopericarditis	Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents	https://www.sciencedirect.com/science/article/pii/S002234762100665X
Myopericarditis	Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-3 doi	https://www.ncbi.nlm.nih.gov/pubmed/34228985
Myopericarditis	Myopericarditis after vaccination with COVID-19 mRNA in adolescents 1to 1years of age	https://www.sciencedirect.com/science/article/pii/S0022347621007368
Myopericarditis	Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34133825/
Myopericarditis	Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34133825
Myopericarditis	Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e doi	https://www.ncbi.nlm.nih.gov/pubmed/34889875
Myopericarditis	Report of a case of myopericarditis after vaccination with BNT162bCOVID-19 mRNA in a young Korean male	https://pubmed.ncbi.nlm.nih.gov/34636504/
Myopericarditis	Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent	https://www.ncbi.nlm.nih.gov/pubmed/34904134
Nephrotic Syndrome	Nephrotic syndrome after ChAdOxnCoV-19 vaccine against SARScoV-2	https://pubmed.ncbi.nlm.nih.gov/34250318/
Nephrotic Syndrome	New-onset nephrotic syndrome after Janssen COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34342187/
Nerve And Muscle Adverse Events	Nerve and muscle adverse events after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34452064/
Neuroimaging Findings in Post COVID-19 Vaccination	Spectrum of neuroimaging findings in post-CoVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34842783/
Neurologic Phantosmia	Unique imaging findings of neurologic phantosmia after Pfizer-BioNtech COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34096896/
Neurological Autoimmune Diseases	Neurological autoimmune diseases after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34668274/
Neurological Symptoms	Neurological complications after the first dose of COVID-19 vaccines and SARS CoV-infection	https://pubmed.ncbi.nlm.nih.gov/34697502/
Neurological Symptoms	Neurological side effects of SARS-CoV-vaccines	https://pubmed.ncbi.nlm.nih.gov/34750810/
Neurological Symptoms	Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine	https://www.sciencedirect.com/science/article/pii/S0899707121003557.
Neurological Symptoms	n-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines	https://pubmed.ncbi.nlm.nih.gov/34688190/
Neurological Symptoms	Spectrum of neurological complications after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34719776/
Neuromyelitis Optica	Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19	https://pubmed.ncbi.nlm.nih.gov/34189662/
Neuromyelitis Optica	Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus mRNA-1273	https://pubmed.ncbi.nlm.nih.gov/34660149/
Ocular Adverse Events	Ocular adverse events following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34559576/
Oculomotor Paralysis	Transient oculomotor paralysis after administration of RNA-127messenger vaccine for SARS-CoV-diplopia after COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34369471/
Orofacial	Reported orofacial adverse effects from COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/33527524/
Pancreas Allograft Rejection	Pancreas allograft rejection after ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34781027/
Parsonage-Turner Syndrome	Parsonage-Turner syndrome associated with SARS-CoV-or SARS-CoV- vaccination. Comment on	https://pubmed.ncbi.nlm.nih.gov/34139321/
Pathophysiologic Alterations	Extensive investigations revealed consistent pathophysiologic alterations after vaccination with COVID-19 vaccines	https://www.nature.com/articles/s41421-021-00329-3
Pericarditis	A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States	https://pubmed.ncbi.nlm.nih.gov/34635376/
Pericarditis	Acute myocarditis after the second dose of SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34236331/
Pericarditis	Acute pericarditis and cardiac tamponade after vaccination with Covid-19	https://pubmed.ncbi.nlm.nih.gov/34749492/
Pericarditis	Pericarditis after administration of BNT162bmRNA COVID-19 mRNA vaccine	https://www.sciencedirect.com/science/article/pii/S1885585721002218
Pericarditis	Pericarditis after administration of COVID-19 mRNA BNT162bvaccine	https://pubmed.ncbi.nlm.nih.gov/34364831/
Pericarditis	Pericarditis after administration of the BNT162bmRNA vaccine COVID-19	https://pubmed.ncbi.nlm.nih.gov/34149145/
Pericarditis	Unusual presentation of acute pericarditis after vaccination against SARS-COV- mRNA-123Modern	https://pubmed.ncbi.nlm.nih.gov/34447639/
Perimyocarditis	Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34515024/
Perimyocarditis	Perimyocarditis after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34866957/
Perimyocarditis	Perimyocarditis following first dose of the mRNA-127SARS-CoV- (Moderna) vaccine in a healthy young male	https://www.ncbi.nlm.nih.gov/pubmed/34348657
Perimyocarditis	Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine	https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543
Perimyocarditis	Unusual Presentation of Acute Perimyocarditis Following SARS-COV-mRNA-123Moderna Vaccination. Cureus, 13(7), e16590. doi	https://www.ncbi.nlm.nih.gov/pubmed/34447639
Perimyocarditis	Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-9doi	https://www.ncbi.nlm.nih.gov/pubmed/34270752
Petechiae (also includes	Petechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34513435/
Polyarthralgia	Polyarthralgia and myalgia syndrome after vaccination with ChAdOxnCOV-19	https://pubmed.ncbi.nlm.nih.gov/34463066/
Post-Mortem	A look at the role of postmortem immunohistochemistry in understanding the inflammatory pathophysiology of COVID-19 disease and vaccine-related thrombotic adverse events	https://pubmed.ncbi.nlm.nih.gov/34769454/
Post-Mortem	COVID-19 vaccine and death	https://pubmed.ncbi.nlm.nih.gov/34073536/
Post-Mortem	Post-mortem investigation of deaths after vaccination with COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34591186/
Post-Mortem	Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review	https://www.ncbi.nlm.nih.gov/pubmed/34945172
Pregnant Woman	Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons	https://www.nejm.org/doi/full/10.1056/NEJMoa2104983
Prion Disease	COVID-19 RNA-based vaccines and the risk of prion disease	https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-disease-1503.pdf
Process-Related Impurities	Process-related impurities in the ChAdOxnCov-19 vaccine	https://www.researchsquare.com/article/rs-477964/v1
Psoriasis	Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b vaccines	https://pubmed.ncbi.nlm.nih.gov/34427024/
Psoriasis	Onset / outbreak of psoriasis after Corona virus ChAdOxnCoV-19 vaccine (Oxford AstraZeneca / Covishield)	https://pubmed.ncbi.nlm.nih.gov/34350668/
Pulmonary Embolism	A case of acute pulmonary embolism after immunization with SARS-CoV-mRNA	https://pubmed.ncbi.nlm.nih.gov/34452028/
Pulmonary Embolism	Isolated pulmonary embolism after COVID vaccination	https://pubmed.ncbi.nlm.nih.gov/34804412/
Pulmonary Embolism	Myocardial infarction, stroke, and pulmonary embolism after BNT162bmRNA COVID-19 vaccine in persons aged 7years or older	https://pubmed.ncbi.nlm.nih.gov/34807248/
Purpura Annularis Telangiectodes	Generalized purpura annularis telangiectodes after SARS-CoV-mRNA vaccination	https://pubmed.ncbi.nlm.nih.gov/34236717/
Refractory Status Epilepticus	New-onset refractory status epilepticus after chadoxncov-19 vaccination	https://www.sciencedirect.com/science/article/pii/s0165572821001569
Rhabdomyolysis	Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination	https://pubmed.ncbi.nlm.nih.gov/34659268/
Rhabdomyolysis	COVID-19 vaccine-induced rhabdomyolysis	https://pubmed.ncbi.nlm.nih.gov/34186348/
Rhabdomyolysis	Rhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34435250/
Rhabdomyolysis	Rhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34435250/
Safety in Adolescents	COVID-19 Vaccine Safety in Adolescents Aged 12-1Years – United States, December 14, 2020-July 16, 20MMWR Morb Mortal Wkly Rep, 70(31), 1053-10doi	https://www.ncbi.nlm.nih.gov/pubmed/34351881
Safety in Adolescents	Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doi	https://www.ncbi.nlm.nih.gov/pubmed/34492161
Safety Monitoring of the Janssen Vaccine	Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine – United States, March-April 20MMWR Morb Mortal Wkly Rep, 70(18), 680-6 doi	https://www.ncbi.nlm.nih.gov/pubmed/33956784
Sensorineural Hearing Loss	Sudden sensorineural hearing loss after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34670143/
Serious Adverse Events Among Health Care Professionals	Prevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOxnCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021	https://pubmed.ncbi.nlm.nih.gov/34819146/
Shingles (includes term	Shingles-like skin lesion after vaccination with AstraZeneca for COVID-19	https://pubmed.ncbi.nlm.nih.gov/34631069/
Skin Reactions	A case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University	https://pubmed.ncbi.nlm.nih.gov/34423106/
Skin Reactions	Skin reactions after vaccination against SARS-COV-2	https://pubmed.ncbi.nlm.nih.gov/34254291/
Skin Reactions	Skin reactions reported after Moderna and Pfizer’s COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33838206/
Squamous Cell Carcinoma	Squamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)	https://pubmed.ncbi.nlm.nih.gov/34612003/
Still’s Disease	An outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patient	https://pubmed.ncbi.nlm.nih.gov/34797392/
Sweet’s Syndrome	Sweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman	https://pubmed.ncbi.nlm.nih.gov/34590397/
Systemic Lupus Erythematosus	Effective DNA damage response after acute but not chronic immune challenge	https://www.ncbi.nlm.nih.gov/pubmed/34089859
Systemic Lupus Erythematosus	Induction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34291477/
Takotsubo cardiomyopathy	Takotsubo (stress) cardiomyopathy after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34625447/
Takotsubo cardiomyopathy	Takotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysis	https://pubmed.ncbi.nlm.nih.gov/34731486/
Takotsubo cardiomyopathy	Takotsubo cardiomyopathy after vaccination with mRNA COVID-19	https://www.sciencedirect.com/science/article/pii/S1443950621011331
Takotsubo cardiomyopathy	Takotsubo syndrome after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34539938/
Thrombocytopenia	A case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOxnCoV-19 against SARS-CoV-2	https://pubmed.ncbi.nlm.nih.gov/34137813/
Thrombocytopenia	A case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosis	https://pubmed.ncbi.nlm.nih.gov/34059191/
Thrombocytopenia	A prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccination	https://europepmc.org/article/PPR/PPR304469435.
Thrombocytopenia	A rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital	https://pubmed.ncbi.nlm.nih.gov/34535492/
Thrombocytopenia	Abdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34546343/
Thrombocytopenia	Acquired thrombotic thrombocytopenic thrombocytopenic purpura	https://pubmed.ncbi.nlm.nih.gov/34105247/
Thrombocytopenia	Adenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndrome	https://pubmed.ncbi.nlm.nih.gov/34407607/
Thrombocytopenia	An observational study to identify the prevalence of thrombocytopenia and anti-PF/ polyanion antibodies in Norwegian health care workers after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33909350/
Thrombocytopenia	Australian and New Zealand approach to the diagnosis and treatment of vaccine induced immune thrombosis and immune thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34490632/
Thrombocytopenia	Bilateral thalamic stroke	https://pubmed.ncbi.nlm.nih.gov/34820232/
Thrombocytopenia	A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination	https://pubmed.ncbi.nlm.nih.gov/34751013/
Thrombocytopenia	Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford AstraZeneca COVID-19	https://pubmed.ncbi.nlm.nih.gov/34033927/
Thrombocytopenia	Cerebral venous vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34373413/
Thrombocytopenia	ChAdOx1 interacts with CAR and PFwith implications for thrombosis with thrombocytopenia syndrome	https://www.science.org/doi/10.1126/sciadv.abl8213
Thrombocytopenia	ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34483267/
Thrombocytopenia	Complicated of long-term vaccine-induced thrombotic immune thrombocytopenia A	https://pubmed.ncbi.nlm.nih.gov/34835275/
Thrombocytopenia	COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity	https://pubmed.ncbi.nlm.nih.gov/34509271/
Thrombocytopenia	COVID-19 vaccine-induced thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34527501/
Thrombocytopenia	Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad2COVS	https://www.sciencedirect.com/science/article/pii/S0196064421003425
Thrombocytopenia	Exacerbation of immune thrombocytopenia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34075578/
Thrombocytopenia	Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins	https://pubmed.ncbi.nlm.nih.gov/34382387/
Thrombocytopenia	Images of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33962903/
Thrombocytopenia	Immune complexes, innate immunity and NETosis in ChAdOxvaccine-induced thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34405870/
Thrombocytopenia	Immune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australia	https://pubmed.ncbi.nlm.nih.gov/34756770/
Thrombocytopenia	Immune thrombocytopenia after vaccination during the COVID-19 pandemic	https://pubmed.ncbi.nlm.nih.gov/34435486/
Thrombocytopenia	Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33476455/
Thrombocytopenia	Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOxnCov-19)	https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.
Thrombocytopenia	Immune-mediated thrombocytopenia associated with Ad2COVS vaccine (Janssen; Johnson & Johnson)	https://pubmed.ncbi.nlm.nih.gov/34469919/
Thrombocytopenia	Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman	https://pubmed.ncbi.nlm.nih.gov/34513446/
Thrombocytopenia	Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34646685/
Thrombocytopenia	Lethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 2COVS	https://pubmed.ncbi.nlm.nih.gov/34626338/
Thrombocytopenia	Limb ischemia and pulmonary artery thrombosis after ChAdOxnCoV-19 vaccine (Oxford-AstraZeneca)	https://pubmed.ncbi.nlm.nih.gov/33990339/
Thrombocytopenia	Neurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-vaccination in vaccine-induced thrombotic thrombocytopenia-VITT	https://pubmed.ncbi.nlm.nih.gov/34202817/
Thrombocytopenia	Newly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccination	https://pubmed.ncbi.nlm.nih.gov/34420249/
Thrombocytopenia	Peduncular, symptomatic cavernous bleeding after immune thrombocytopenia induced SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34549178/
Thrombocytopenia	Portal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34598301/
Thrombocytopenia	Procoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34011137/
Thrombocytopenia	Pulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34261635/
Thrombocytopenia	Purpuric rash and thrombocytopenia after mRNA-127(Modern) COVID-19 vaccine	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
Thrombocytopenia	Relapse of immune thrombocytopenia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34591991/
Thrombocytopenia	Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient	https://pubmed.ncbi.nlm.nih.gov/34804803/
Thrombocytopenia	Renal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/34268278/
Thrombocytopenia	Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-positive testing	https://www.ncbi.nlm.nih.gov/pubmed/34446426
Thrombocytopenia	Secondary immune thrombocytopenia (ITP) associated with ChAdOxCovid-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34377889/
Thrombocytopenia	Severe and refractory immune thrombocytopenia occurring after SARS-CoV- vaccination	https://pubmed.ncbi.nlm.nih.gov/33854395/
Thrombocytopenia	Severe immune thrombocytopenia following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34653943/
Thrombocytopenia	Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-Vaccine. J Blood Med, 12, 221-2doi	https://www.ncbi.nlm.nih.gov/pubmed/33854395
Thrombocytopenia	Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34144250/
Thrombocytopenia	Successful treatment of vaccine-induced immune thrombotic thrombocytopenia in a 26-year-old female patient	https://pubmed.ncbi.nlm.nih.gov/34614491/
Thrombocytopenia	Thrombocytopenia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34332437/
Thrombocytopenia	Thrombocytopenia following Pfizer and Moderna SARS CoV-vaccination	https://www.ncbi.nlm.nih.gov/pubmed/33606296
Thrombocytopenia	Thrombocytopenia following Pfizer and Moderna SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/33606296/
Thrombocytopenia	Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34331506/
Thrombocytopenia	Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-33doi	https://www.ncbi.nlm.nih.gov/pubmed/34006408
Thrombocytopenia	Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33877737/
Thrombocytopenia	Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	https://pubmed.ncbi.nlm.nih.gov/34006408/
Thrombocytopenia	Thrombosis and SARS-CoV-vaccines	https://pubmed.ncbi.nlm.nih.gov/34237213/
Thrombocytopenia	Thrombotic thrombocytopenia after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34071883/
Thrombocytopenia	Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad2COVS	https://pubmed.ncbi.nlm.nih.gov/34516272/
Thrombocytopenia	Treatment of acute ischemic stroke associated with ChAdOxnCoV-19 vaccine induced immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34461442/
Thrombocytopenia	Vaccine-induced immune thrombotic thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/34159588/
Thrombocytopenia	Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review	https://www.sciencedirect.com/science/article/pii/S0022510X21003014
Thrombocytopenia	Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOxnCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34171649/
Thrombocytopenia	Vaccine-induced thrombocytopenia with severe headache	https://pubmed.ncbi.nlm.nih.gov/34525282/
Thrombocytopenia	Vaccine-induced thrombotic thrombocytopenia after Ad2COVS vaccination in a man presenting as acute venous thromboembolism	https://pubmed.ncbi.nlm.nih.gov/34096082/
Thrombocytopenia	Venous thromboembolism and mild thrombocytopenia after ChAdOxnCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34384129/
Thrombocytopenia	Venous thromboembolism and mild thrombocytopenia after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34384129/
Thrombocytopenia	VITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34731555/
Thrombophilia	Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination	https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ
Thrombophlebitis	Idiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19)	https://pubmed.ncbi.nlm.nih.gov/33624509/
Thrombosis	0.Case study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34781321/
Thrombosis	59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism days after a first dose of Pfizer-BioNTech BNT162bmRNA vaccine COVID-19	https://pubmed.ncbi.nlm.nih.gov/34117206/
Thrombosis	A case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162bvaccine (Pfizer-Biontech)	https://pubmed.ncbi.nlm.nih.gov/34820240/
Thrombosis	A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis	https://pubmed.ncbi.nlm.nih.gov/34843991/
Thrombosis	Acute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOxnCov-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34175640/
Thrombosis	Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/34580132/
Thrombosis	Acute thrombosis of the coronary tree after vaccination against COVID-19	https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988
Thrombosis	Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad2COVS COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34724036/
Thrombosis	An unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34790811/
Thrombosis	Anaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34863404/
Thrombosis	Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia	https://www.nature.com/articles/s41586-021-03744-4
Thrombosis	Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway	https://pubmed.ncbi.nlm.nih.gov/33952445/
Thrombosis	Atypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca)	https://pubmed.ncbi.nlm.nih.gov/34083026/
Thrombosis	Autoimmune roots of thrombotic events after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34508917/
Thrombosis	Autoimmunity roots of thrombotic events after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34508917/
Thrombosis	Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/33864750/
Thrombosis	CAd2COV2-S vaccination may reveal hereditary thrombophilia	https://pubmed.ncbi.nlm.nih.gov/34632750/
Thrombosis	Carotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34312301/
Thrombosis	Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination	https://pubmed.ncbi.nlm.nih.gov/34609603/
Thrombosis	Case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital	https://pubmed.ncbi.nlm.nih.gov/34694650/
Thrombosis	celiac artery and splenic artery thrombosis complicated by splenic infarction days after the first dose of Oxford vaccine, causal relationship or coincidence	https://pubmed.ncbi.nlm.nih.gov/34261633/
Thrombosis	Cerebral venous sinus thrombosis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34327553/
Thrombosis	Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34783932/
Thrombosis	Cerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2	https://pubmed.ncbi.nlm.nih.gov/34796065/
Thrombosis	Cerebral venous sinus thrombosis following vaccination with ChAdOx1	https://pubmed.ncbi.nlm.nih.gov/34706921/
Thrombosis	Cerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2)	https://pubmed.ncbi.nlm.nih.gov/34595867/
Thrombosis	Cerebral venous sinus thrombosis negative for anti-PFantibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation	https://pubmed.ncbi.nlm.nih.gov/34186376/
Thrombosis	Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man	https://pubmed.ncbi.nlm.nih.gov/34630307/
Thrombosis	Characteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-vaccine	https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622
Thrombosis	Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOxnCov-19; https	https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.
Thrombosis	Clinical features of vaccine-induced thrombocytopenia and immune thrombosis	https://pubmed.ncbi.nlm.nih.gov/34379914/
Thrombosis	Comments on thrombosis after vaccination	https://pubmed.ncbi.nlm.nih.gov/34788138
Thrombosis	Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database	https://pubmed.ncbi.nlm.nih.gov/34375510/
Thrombosis	Comparison of vaccine-induced thrombotic episodes between ChAdOxnCoV-19 and Ad2COV.S vaccines	https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895
Thrombosis	Comparison of vaccine-induced thrombotic events between ChAdOxnCoV-19 and Ad2COV.S vaccines	https://pubmed.ncbi.nlm.nih.gov/34139631/
Thrombosis	Concerns for adverse effects of thrombocytopenia and thrombosis after adenovirus vectored COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34541935/
Thrombosis	Coronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/34033367/
Thrombosis	COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS)	https://pubmed.ncbi.nlm.nih.gov/34698582/
Thrombosis	COVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation	https://pubmed.ncbi.nlm.nih.gov/34624910/
Thrombosis	COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia	https://www.sciencedirect.com/science/article/pii/S1665268121000557
Thrombosis	COVID-19 vaccine-induced thrombosis	https://pubmed.ncbi.nlm.nih.gov/34802488/
Thrombosis	Covid-19 vaccine-induced thrombosis and thrombocytopenia	https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505
Thrombosis	Cutaneous thrombosis associated with cutaneous necrosis following Oxford AstraZeneca COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34189756/
Thrombosis	Deep venous thrombosis after vaccination with Ad2COVS in adult males	https://pubmed.ncbi.nlm.nih.gov/34659839/
Thrombosis	Deep venous thrombosis more than two weeks after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/33928773/
Thrombosis	Delayed headache after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34535076/
Thrombosis	Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34782400/
Thrombosis	First dose of ChAdOxand BNT162bCOVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland	https://www.nature.com/articles/s41591-021-01408-4
Thrombosis	Genital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA	https://pubmed.ncbi.nlm.nih.gov/34839563/
Thrombosis	Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-vaccination	https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315
Thrombosis	Idiopathic thrombocytopenic purpura and the Modern Covid-19 vaccine	https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext
Thrombosis	Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19 (AstraZeneca)	https://pubmed.ncbi.nlm.nih.gov/34402666/
Thrombosis	Immediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein	https://pubmed.ncbi.nlm.nih.gov/34023956/
Thrombosis	Immune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2	https://www.sciencedirect.com/science/article/pii/S2214250921002018
Thrombosis	Immune thrombocytopenia following Pfizer-BioNTech BNT162bmRNA COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34155844/
Thrombosis	Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccination	https://casereports.bmj.com/content/14/7/e242678.
Thrombosis	Immune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33987882/
Thrombosis	Immunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34107198/
Thrombosis	Inflammation and platelet activation after COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34887867/
Thrombosis	Information on ChAdOxnCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34587242/
Thrombosis	Intracerebral haemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34402235/
Thrombosis	Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOxnCOVID-19 vaccination in a pregnant woman	https://pubmed.ncbi.nlm.nih.gov/34261297/
Thrombosis	Ischemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34035134/
Thrombosis	Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34138513/
Thrombosis	Major artery thrombosis and vaccination against ChAdOxnCov-19	https://pubmed.ncbi.nlm.nih.gov/34839830/
Thrombosis	Malignant cerebral infarction after vaccination with ChAdOxnCov-19	https://pubmed.ncbi.nlm.nih.gov/34341358/
Thrombosis	Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-vaccine-induced thrombosis and thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/34097311/
Thrombosis	Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca)	https://pubmed.ncbi.nlm.nih.gov/33871350/
Thrombosis	Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-infection	https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706
Thrombosis	Multiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx(AstraZeneca), which required emergency femoral and carotid surgical thrombectomy	https://pubmed.ncbi.nlm.nih.gov/34644642/
Thrombosis	Myocardial infarction and azygos vein thrombosis after vaccination with ChAdOx nCoV-19 in a hemodialysis patient	https://pubmed.ncbi.nlm.nih.gov/34650896/
Thrombosis	Neuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34726934/
Thrombosis	New portal vein thrombosis in cirrhosis	https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext
Thrombosis	Newly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administration	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/
Thrombosis	Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34876440/
Thrombosis	Palmar digital vein thrombosis after Oxford-AstraZeneca COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34473841/
Thrombosis	PFimmunoassays in vaccine-induced thrombotic thrombocytopenia	https://www.nejm.org/doi/full/10.1056/NEJMc2106383
Thrombosis	Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × nCov-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34474550/
Thrombosis	Portal vein thrombosis associated with ChAdOxnCov-19 vaccine	https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/
Thrombosis	Portal vein thrombosis occurring after the first dose of SARS-CoV-mRNA vaccine in a patient with antiphospholipid syndrome	https://www.sciencedirect.com/science/article/pii/S2666572721000389
Thrombosis	Possible triggers of thrombocytopenia and/or hemorrhage by BNT162bvaccine, Pfizer-BioNTech	https://pubmed.ncbi.nlm.nih.gov/34660652/
Thrombosis	Post-mortem findings in vaccine-induced thrombotic thrombocytopenia	https://haematologica.org/article/view/haematol.2021.279075
Thrombosis	Potential risk of thrombotic events after COVID-19 vaccination with Oxford AstraZeneca in women receiving estrogen	https://pubmed.ncbi.nlm.nih.gov/34734086/
Thrombosis	Predicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34254476/
Thrombosis	Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34545400/
Thrombosis	Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOxnCoV-19 vaccine (VITT)	https://pubmed.ncbi.nlm.nih.gov/34256983/
Thrombosis	Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOxnCoV-19 vaccine (VITT)	https://www.sciencedirect.com/science/article/pii/S0953620521002363
Thrombosis	Procoagulant microparticles	https://pubmed.ncbi.nlm.nih.gov/34129181/
Thrombosis	Prothrombotic immune thrombocytopenia after COVID-19 vaccination	https://www.sciencedirect.com/science/article/pii/S0006497121009411
Thrombosis	Rare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosis	https://pubmed.ncbi.nlm.nih.gov/34556531/
Thrombosis	Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE)	https://pubmed.ncbi.nlm.nih.gov/34672380/
Thrombosis	Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34462996/
Thrombosis	Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-tests	https://pubmed.ncbi.nlm.nih.gov/34446426/
Thrombosis	Roots of autoimmunity of thrombotic events after COVID-19 vaccination	https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160
Thrombosis	Secondary immune thrombocytopenia putatively attributable to COVID-19 vaccination	https://casereports.bmj.com/content/14/5/e242220.abstract.
Thrombosis	Severe vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34355379/
Thrombosis	Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination	https://www.ncbi.nlm.nih.gov/pubmed/34408937
Thrombosis	The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia	https://pubmed.ncbi.nlm.nih.gov/34455073/
Thrombosis	Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination	https://pubmed.ncbi.nlm.nih.gov/34352418/
Thrombosis	Three cases of acute venous thromboembolism in women after vaccination against COVID-19	https://www.sciencedirect.com/science/article/pii/S2213333X21003929
Thrombosis	Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34132839/
Thrombosis	Thrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/
Thrombosis	Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”	https://pubmed.ncbi.nlm.nih.gov/33918932/
Thrombosis	Thrombocytopenia and splanchnic thrombosis after vaccination with Ad2COVS successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy	https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
Thrombosis	Thromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34264151/
Thrombosis	Thrombosis after adenovirus-vectored COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34755555/
Thrombosis	Thrombosis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34479129/
Thrombosis	Thrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19	https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?
Thrombosis	Thrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad2COVS vaccine (Janssen)	https://pubmed.ncbi.nlm.nih.gov/34670287/
Thrombosis	Thrombosis formation after COVID-19 vaccination immunologic aspects	https://pubmed.ncbi.nlm.nih.gov/34629931/
Thrombosis	Thrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34649281/
Thrombosis	Thrombosis in pre- and post-vaccination phase of COVID-19; https	https://pubmed.ncbi.nlm.nih.gov/34650382/
Thrombosis	Thrombosis with thrombocytopenia after Messenger vaccine RNA-1273	https://pubmed.ncbi.nlm.nih.gov/34181446/
Thrombosis	Thrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOxnCoV-19 (AZD1222) COVID-19	https://pubmed.ncbi.nlm.nih.gov/34272095/
Thrombosis	Thrombosis with thrombocytopenia syndrome after COVID-19 immunization	https://pubmed.ncbi.nlm.nih.gov/34236343/
Thrombosis	Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines	https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381
Thrombosis	Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines	https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904
Thrombosis	Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines	https://pubmed.ncbi.nlm.nih.gov/34835256/
Thrombosis	Thrombotic events after COVID-19 vaccination in over 50 years of age	https://pubmed.ncbi.nlm.nih.gov/34835237/
Thrombosis	Thrombotic immune thrombocytopenia induced by SARS-CoV-vaccine	https://www.nejm.org/doi/full/10.1056/nejme2106315
Thrombosis	Thrombotic thrombocytopenia after vaccination with ChAdOxnCov-19	https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?
Thrombosis	Understanding the risk of thrombosis with thrombocytopenia syndrome following Ad2COVS vaccination	https://pubmed.ncbi.nlm.nih.gov/34595694/
Thrombosis	Unusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19)	https://pubmed.ncbi.nlm.nih.gov/34840204/
Thrombosis	US s of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad2COVS (against covid-19), March to April 21, 2020	https://pubmed.ncbi.nlm.nih.gov/33929487/
Thrombosis	Vaccine-Associated Thrombocytopenia and Thrombosis	https://www.ncbi.nlm.nih.gov/pubmed/34833382
Thrombosis	Vaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus vaccination	https://pubmed.ncbi.nlm.nih.gov/34664303/
Thrombosis	Vaccine-induced immune thrombotic immune thrombocytopenia (VITT)	https://pubmed.ncbi.nlm.nih.gov/33851389/
Thrombosis	Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage	https://pubmed.ncbi.nlm.nih.gov/34235757/
Thrombosis	Vaccine-induced thrombotic thrombocytopenia	https://www.sciencedirect.com/science/article/pii/S2589936821000256
Thrombosis	Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic	https://www.sciencedirect.com/science/article/pii/S0953620521002314
Thrombotic Thrombocytopenic Purpura	Immune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer BioNTech BNT16B2b2	https://pubmed.ncbi.nlm.nih.gov/34077572/
Thrombotic Thrombocytopenic Purpura	Severe immune thrombocytopenic purpura after SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34754937/
Thrombotic Thrombocytopenic Purpura	Thrombotic thrombocytopenic purpura	https://pubmed.ncbi.nlm.nih.gov/34264514/
Thrombotic Thrombocytopenic Purpura	Thrombotic thrombocytopenic purpura after vaccination with Ad2COV2-S	https://pubmed.ncbi.nlm.nih.gov/33980419/
Thymic hyperplasia	Thymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19	https://pubmed.ncbi.nlm.nih.gov/34462647/
Thyroiditis	Three cases of subacute thyroiditis after SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34043800/
Tolosa-Hunt syndrome	Tolosa-Hunt syndrome occurring after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34513398/
Toxic Epidermal Necrolysis	A case of toxic epidermal necrolysis after vaccination with ChAdOxnCoV-19 (AZD1222)	https://pubmed.ncbi.nlm.nih.gov/34751429/
Urticaria	Increased risk of urticaria/angioedema after BNT162bmRNA COVID-19 vaccination in health care workers taking ACE inhibitors	https://pubmed.ncbi.nlm.nih.gov/34579248/
Uveitis	Bilateral uveitis after inoculation with COVID-19 vaccine	https://www.sciencedirect.com/science/article/pii/S1201971221007797
Varicella Zoster Virus	Acute retinal necrosis due to varicella zoster virus reactivation after vaccination with BNT162bCOVID-19 mRNA	https://pubmed.ncbi.nlm.nih.gov/34851795/
Vasculitis	A case of ANCA-associated vasculitis after AZD122(Oxford-AstraZeneca) SARS CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34416184/
Vasculitis	A case of generalized Sweet’s syndrome with vasculitis triggered by recent vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34849386/
Vasculitis	A case of leukocytoclastic vasculitis after vaccination with a SARS-CoVvaccine	https://pubmed.ncbi.nlm.nih.gov/34196469/
Vasculitis	ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine	https://www.sciencedirect.com/science/article/pii/S0272638621007423
Vasculitis	Asymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophils	https://pubmed.ncbi.nlm.nih.gov/34115904/
Vasculitis	Case of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019	https://pubmed.ncbi.nlm.nih.gov/34535924/
Vasculitis	COVID-19 vaccine-induced urticarial vasculitis	https://pubmed.ncbi.nlm.nih.gov/34369046/
Vasculitis	Cutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34660867/
Vasculitis	Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34327795
Vasculitis	Cutaneous lymphocytic vasculitis after administration of the second dose of AZD122(Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus vaccine	https://pubmed.ncbi.nlm.nih.gov/34726187/
Vasculitis	Cutaneous small vessel vasculitis after COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34529877/
Vasculitis	Cutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad2COVS	https://pubmed.ncbi.nlm.nih.gov/34337124/
Vasculitis	Cutaneous vasculitis after severe acute respiratory syndrome coronavirus vaccine	https://pubmed.ncbi.nlm.nih.gov/34557622/
Vasculitis	First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2	https://pubmed.ncbi.nlm.nih.gov/34530771/
Vasculitis	Granulomatous vasculitis after AstraZeneca anti-SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34237323/
Vasculitis	IgA vasculitis following COVID-19 vaccination in an adult	https://pubmed.ncbi.nlm.nih.gov/34779011/
Vasculitis	IgA vasculitis in adult patient after vaccination with ChadOxnCoV-19	https://pubmed.ncbi.nlm.nih.gov/34509658/
Vasculitis	Imaging in vascular medicine	https://pubmed.ncbi.nlm.nih.gov/34720009/
Vasculitis	Induction of cutaneous leukocytoclastic vasculitis after ChAdOxnCoV-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34853744/
Vasculitis	Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34783899/
Vasculitis	Leukocytoclastic vasculitis after coronavirus disease vaccination 2019	https://pubmed.ncbi.nlm.nih.gov/34713472/803
Vasculitis	Leukocytoclastic vasculitis after exposure to COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34836739/
Vasculitis	Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOxcorona virus vaccine nCoV-19 (recombinant)	https://pubmed.ncbi.nlm.nih.gov/34546608/
Vasculitis	Nephrotic syndrome and vasculitis after SARS-CoV-vaccine	https://pubmed.ncbi.nlm.nih.gov/34245294/
Vasculitis	New-onset leukocytoclastic vasculitis after COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/34241833/
Vasculitis	Occurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19)	https://pubmed.ncbi.nlm.nih.gov/34599716/
Vasculitis	Outbreak of leukocytoclastic vasculitis after COVID-19 vaccine	https://pubmed.ncbi.nlm.nih.gov/33928638/
Vasculitis	Outbreaks of mixed cryoglobulinemia vasculitis after vaccination against SARS CoV-2	https://pubmed.ncbi.nlm.nih.gov/34819272/
Vasculitis	Possible case of COVID-19 mRNA vaccine-induced small-vessel vasculitis	https://pubmed.ncbi.nlm.nih.gov/34705320/
Vasculitis	Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis following vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34451967/
Vasculitis	Reactivation of IgA vasculitis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34250509/
Vasculitis	Reactivation of IgA vasculitis after vaccination with COVID-19	https://pubmed.ncbi.nlm.nih.gov/34848431/
Vasculitis	Relapse of microscopic polyangiitis after COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34251683/
Vasculitis	Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS CoV-2	https://pubmed.ncbi.nlm.nih.gov/34310763/
Vasculitis	Varicella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccination	https://pubmed.ncbi.nlm.nih.gov/34310759/
Vasculitis	Vasculitis and bursitis in [ 1F] FDG-PET/CT after COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34495381/
Vesiculobullous cutaneous reactions	Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine	https://pubmed.ncbi.nlm.nih.gov/34236711/
Vogt-Koyanagi-Harada syndrome	Reactivation of Vogt-Koyanagi-Harada disease under control for more than years, after anti-SARS-CoV-vaccination	https://pubmed.ncbi.nlm.nih.gov/34224024/
Vogt-Koyanagi-Harada syndrome	Vogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOxnCoV-19 (AZD1222) vaccination	https://pubmed.ncbi.nlm.nih.gov/34462013/
V-REPP vaccine-related eruption of papules and plaques.	Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V REPP	https://www.sciencedirect.com/science/article/pii/S0190962221024427

---

By Dr. Dannielle (Dossy) Blumenthal. All opinions are the author’s own. Public domain.